Sexual behaviours, HIV testing, and the proportion of men at risk of transmitting and acquiring HIV in London, UK, 2000-13: a serial cross-sectional study by Aghaizu, A et al.
1 
 
Understanding continuing high HIV incidence: trends in sexual behaviours, HIV testing and 1 
the proportion of men at risk of transmitting and acquiring HIV in London 2000-2013. A serial 2 
cross-sectional study. 3 
 4 
Abstract 5 
Background: HIV incidence among men who have sex with men (MSM) in the UK has remained unchanged 6 
over the last decade despite increases in HIV testing and antiretroviral (ARV) coverage. Here we examine 7 
trends in sexual behaviours and HIV testing among MSM, and explore risk of transmitting and acquiring 8 
HIV. 9 
Methods: Ten cross-sectional surveys between 2000 and 2013 using self-administered questionnaires and 10 
oral HIV antibody testing among MSM in London gay social venues.  11 
 12 
Findings: Of 11,876 MSM recruited, 12.7% (n=1512) were HIV positive with no significant trend over time. 13 
Of these, 35.3% (531/1505) had undiagnosed infection which over time declined from 34.4% (45/131) to 14 
23.6% (25/106) (p=0.01) as recent HIV testing (in the last 12 months) increased from 26.4% (263/997) to 15 
60.1% (467/777) (p<0.001). The increase in recent testing among the undiagnosed (from 28.6% to 66.7%, 16 
p<0.001) and negative (from 26.2% to 61.7%, p<0.001) suggests undiagnosed infection may be 17 
increasingly recently acquired infection. 18 
Over the study period, the proportion reporting unprotected anal intercourse (UAI) during the previous 19 
year increased from 43.2% (513/1187) to 52.6% (394/749) (p<0.001) and serosorting (exclusively) 20 
increased from 18.3% (207/1132) to 27.7% (177/6369) (p<0.001). Overall, one in 43 (2.3%, 268/11570) 21 
had undiagnosed infection and reported UAI and were therefore at risk of transmitting HIV. A further one 22 
in 45 (2.2%, 259/11570) had diagnosed infection and reported UAI and not exclusively serosorting in the 23 
previous year. Whilst we did not collect data on ARV or viral load, surveillance data suggest that a small 24 
proportion of the latter group will have detectable viral load and hence be at risk of transmitting HIV. One 25 
in four HIV negative men (25.4%, 2633/10364) were at higher risk of acquiring HIV (defined as HIV 26 
negative MSM either reporting ≥1 casual UAI partner(s) in the previous year or not exclusively 27 
serosorting). The proportions of men at risk of transmission or acquisition changed little over time. 28 
Undiagnosed men reporting UAI and diagnosed men not exclusively serosorting had consistently higher 29 
partner numbers than other MSM over the period. 30 
 31 
Interpretation:  Undiagnosed HIV may be increasingly recently acquired infection, during which persons 32 
are most infectious. This coupled with the high partner numbers of a core group of MSM at risk of 33 
transmitting HIV, and the lack of decline in the proportion of men at higher risk of acquiring the infection, 34 
may explain the sustained HIV incidence.  35 
 36 
Funding: Public Health England 37 
 38 
 39 
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Introduction 40 
Men who have sex with men (MSM) continue to be at highest risk of acquiring HIV in the UK.  Since 2000, 41 
the annual number of new HIV diagnoses among MSM has increased from 1,830 to 3,270 in 2013.1;2 Two 42 
studies have shown estimated HIV incidence over this period to have remained stable (increasing slightly), 43 
and is currently at a level similar to the annual number of new HIV diagnoses (in 2013, 2800 new infections 44 
estimated).3;4 One of these studies uses a back-calculation approach based on CD4 cell count at diagnosis3; 45 
the second is a dynamic model of sexual behaviours4. Given the greatly increased uptake of HIV testing 46 
and antiretroviral (ARV) treatment in the last decade, which, by reducing viral load should reduce 47 
transmission, the sustained level of HIV incidence supports the notion that risk behaviours must have 48 
increased over this period.5;6 Studies suggest, since the introduction of ARVs in the mid 1990’s, the 49 
prevalence of high risk sexual behaviours among MSM is increasing (at least partly) due to ‘treatment 50 
optimism’, relating both to the dramatically reduced morbidity and mortality associated with the 51 
infection,  and the reduced risk of transmission from a positive partner (the latter discovered in later 52 
years).7-10  Few behavioural studies are able to explore trends in sexual behaviours in detail in particular 53 
examining seroadaptive behaviours in relation to a confirmed versus perceived HIV status. Current 54 
guidelines are for MSM to test annually and at least every three months if having UAI with new or casual 55 
partners.1;11;12 Here we examine trends in both sexual risk and HIV testing behaviours against a 56 
background of targeted prevention and testing initiatives among MSM recruited from community venues 57 
in London over the last 14 years. With half of all new HIV diagnoses in the UK occurring in London, these 58 
trends can be used to understand the role of behaviour change and testing in driving continued HIV 59 
transmission. 60 
 61 
Methods 62 
Study population and data collection 63 
The Gay Men’s Sexual Health Survey is a regular community-based survey conducted since 1996. The 64 
survey methods have been described in detail elsewhere.13-15 Briefly, from 2000 to 2013, for each survey, 65 
fieldworkers visited 38-58 bars, clubs and saunas across London over a three month period inviting MSM 66 
to self-complete a short, anonymous questionnaire on demographic and sexual behaviour characteristics, 67 
and provide oral fluid specimen for HIV antibody testing (OraSure Technologies, Inc., Bethlehem, 68 
Pennsylvania, USA). Recruitment was conducted between October and January for all survey years up to 69 
2008; for 2011 and 2013 it was conducted between February and August.  A barcode linked specimens to 70 
the corresponding questionnaire. Fieldworkers explained to participants that the specimens would be 71 
tested for research purposes only and results not returned to them.  All participants were advised to 72 
attend a healthcare setting for a named HIV test if they wanted to know their status. All men aged 16 and 73 
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above in the study venues were eligible to take part and fieldworkers attempted to approach all and 74 
recorded refusal rates.  Ethical approval was granted each year by the UCL research ethics committee 75 
(00/0158). Verbal consent for anonymous saliva samples and self-completion of questionnaires was 76 
obtained to ensure anonymity of all participants. 77 
 78 
Statistical analysis 79 
We defined undiagnosed infection when a participant had a positive Orasure specimen and reported 80 
either that they (i) had never had an HIV test, (ii) perceived themselves to be negative or didn’t know, (iii) 81 
the result of their last test was negative. We defined a casual partner as a partner with whom unprotected 82 
(condomless) anal intercourse (UAI) was reported once only and a regular partner if more than once in 83 
the last year. Exclusively serosorting was defined as having UAI only with partners of presumed same HIV 84 
status in the last year. We refer to it as ‘presumed’ as the HIV status of partners was self-reported by 85 
respondents. This was established using the question ‘In the past year, how many men that you had 86 
active/passive anal intercourse without a condom did you know had the same HIV status as you.’ 87 
 88 
MSM potentially at risk of transmitting HIV were defined as either those with undiagnosed HIV reporting 89 
UAI in the previous year or with diagnosed HIV reporting UAI and not exclusively serosorting in the 90 
previous year. Among the latter group, most may have had undetectable viral load due to ARV treatment 91 
and may therefore not have been at risk of transmitting, but information on ARV treatment and viral load 92 
were not collected in this study.  The implications of this for the interpretation of our findings are 93 
discussed later. MSM at higher risk of acquiring HIV were HIV negative who reported in the previous year 94 
either ≥1 casual UAI partner(s) or not exclusively serosorting.  95 
 96 
Data were analysed using STATA version 13.0 (StataCorp, College Station, Texas, USA). Analyses were 97 
performed stratified by HIV status. We examined the significance of trends over time using linear, logistic 98 
and quantile regression, adjusted for age, with survey year modelled as a linear term. For trends in HIV 99 
testing, overall HIV positivity and undiagnosed HIV, we additionally adjusted for education, employment, 100 
and ethnicity, and assessed linearity using a likelihood ratio test relative to a model with survey year as a 101 
categorical variable. Characteristics of MSM at risk of transmitting and acquiring HIV were explored using 102 
a multivariable model controlling for the year of survey as a linear term (odds ratios for year not shown). 103 
Factors significant to p<0.05 in univariable analyses were included in the multivariable model. 104 
 105 
 106 
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Laboratory procedures 107 
Oral fluid samples collected with the Orasure kit were tested for HIV antibody at Public Health England 108 
(PHE) using GACELISA HIV-1 and 2 (Abbott Laboratories, Maidenhead, UK). All samples were tested for 109 
total immunoglobulin (IgG) to check the specimen quality apart from those collected in 2011, when a two-110 
stage approach was used, firstly by screening with a modified enzyme immunoassay, secondly by re-111 
screening positive specimens with an enzyme immunoassay and a western blot (Genelabs HIV blot 2.2). 112 
 113 
Role of the funding source 114 
The sponsor contributed to the study design, data collection, data analysis, data interpretation and 115 
writing of the report. The corresponding author had full access to all the data in the study and had final 116 
responsibility for the decision to submit for publication. 117 
 118 
Results 119 
A total of 13,861 questionnaires were collected between 2000 and 2013. Response rates ranged between 120 
50% and 70% each year. Venue data were missing for 930 participants (two in 2002, three participants in 121 
2008 and all 925 participants in 2013, however where data were available, 82% (n=10,578) were recruited 122 
from bars, 13% (n=1,636) from clubs, 6% (n=717) from saunas. We excluded 124 questionnaires from men 123 
who completed the survey previously or were heterosexual reporting no anal intercourse in the last year, 124 
leaving 13,737. In addition, 1,861 (13%) men were excluded as they did not provide samples for antibody 125 
testing leaving 11,876. Men who did and did not give samples were similar in age, education and 126 
employment status however differed slightly by ethnicity (5·7% (105/1856) vs. 3·2% (374/11841) black). 127 
Among the 11,876 included, the demographic characteristics of participants were similar over each of the 128 
ten surveys. Overall, the median age was 33 years and most (87%) were of white ethnicity.  129 
 130 
When combining the study years, 12·7% (n=1512/11876) were HIV positive ranging between 8·5% 131 
(n=82/965) and 17·4% (200/1153) over the period (Table 1). A third of positive MSM (35.3%, n=531/1505, 132 
4·5% of the entire sample) were undiagnosed which declined (non-linearly) over the period from 34·4% 133 
(45/131) in 2000 to 23·6% (25/106) in 2013 (p=0.01). Over this period, recent HIV testing (in the last 12 134 
months) increased from 26·4% (263/997) to 60·1% (467/777) (p<0·001). Recent testing increased among 135 
the undiagnosed at a similar level (from 28·6% (10/35) to 66·7% (16/24), p<0.001). The proportion of 136 
MSM ever having had an HIV test increased from 63·1% (629/997) in 2000 to 91·3% (709/777) in 2013 137 
(p=0·004). HIV positivity varied by recruitment venue type with a similar prevalence among MSM in bars 138 
(8·1% (740/9100) diagnosed, 4·3%, (387/9100) undiagnosed) and clubs (6·5% (89/1375) diagnosed, 4·5%, 139 
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(62/1375) undiagnosed) and highest prevalence in saunas (11·5% (71/617) diagnosed, 9·2%, (57/617) 140 
undiagnosed). 141 
 142 
Over the 14 years, there was an increase in the proportion of MSM reporting UAI during the previous year 143 
from 43·2% (513/1187) in 2000 to 52·6% (394/749) in 2013 (p<0·001, Table 2, Figure 1.). This increase 144 
was significant among both negative and diagnosed MSM increasing from 42·3% (448/1058) to 50·9% 145 
(329/647, p<0·001) and 48·8% (41/84) to 63·8% (51/80, p=0·002), respectively. Among undiagnosed 146 
MSM, numbers were small and no clear trend was observed, the prevalence fluctuating between 42·9% 147 
(18/42) and 63·6% (14/22).  148 
 149 
The proportion of MSM who exclusively serosorted increased overall from 18·3% (207/1132) in 2000 to 150 
27·7% (177/639) in 2013; among negative men (with other presumed negative men) this increased, from 151 
18·0% (181/1007) to 27·1% (150/554), among diagnosed men from 21·7% (18/83) to 30·4% (21/69) and 152 
among undiagnosed men (with presumed negative men) from 19·0% (8/42) to 37·5% (6/16). (To note, 153 
among men who perceived themselves to be negative, 2·8% (18/653) had undiagnosed HIV in 2013 with 154 
no significant trend overtime.) 155 
 156 
Alongside this increase in men exclusively serosorting, the proportion of men reporting UAI with partners 157 
of unknown or discordant status declined from 22.3 % (253/1132) in 2000 to 16.7% (107/639) in 2013 158 
(p<0·001) overall, and among negative men from  21.7% (218/1007) to 15.5% (86/554) (p<0·001), from 159 
26.5% (22/83) to 27.5% (19/69) p=0·433) among diagnosed men and from 31.0% (13/42) to 12.5% (2/16) 160 
(p=0.012) among the undiagnosed, respectively. 161 
 162 
Over the 14 years of study, the mean number of sexual partners in the last year was consistently higher 163 
in diagnosed positive MSM and increased significantly in this group from 4·7 (standard deviation (SD) 164 
12·8) partners in 2000 to 9·7 (SD 22·5) in 2013 (p=0·008), after a peak of a mean of 13·5 (SD 36·8) in 2006. 165 
 166 
Between 2000 and 2013, there were 259 diagnosed MSM who reported UAI and were not exclusively 167 
serosorting, some of whom may have been at risk of transmitting HIV. There were a further 268 168 
undiagnosed HIV positive MSM who reported UAI. Together, they represented 4·6% (527/11570) of MSM 169 
overall (Table 3). The overall proportion of MSM potentially at risk of transmitting HIV remained stable 170 
over the period, as did the fraction of men in this group that were diagnosed and undiagnosed. Both 171 
diagnosed and undiagnosed MSM potentially at risk of transmitting HIV had consistently higher UAI 172 
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partners numbers compared to all other MSM, while the mean number of partners increased over time 173 
for all groups; in 2013 undiagnosed men at risk of transmitting reported a mean of 11·6 (SD 16·1) and 174 
median of 2·5 (interquartile range (IQR) 1, 20) UAI partners in the last year; diagnosed MSM, of whom 175 
some may be at risk of transmitting, reported a mean of 22·4 (SD 30) and median 10 (IQR 2,28) compared 176 
to other MSM with 2·2 (SD 13·1) and 1 (IQR 0, 1), respectively. This demonstrates the skewed distribution 177 
of partner numbers, with no increase over time for the majority (medians largely unchanged) but an 178 
increase in partners for the fraction in the upper end of the distribution so that the mean is increased. 179 
Multivariable analyses revealed that MSM were more likely to be at risk of transmitting HIV (compared 180 
to all other MSM) if they were older (Adjusted Odds Ratios (AOR) 35-44 years compared to 16-24 years 181 
2·7 (95% confidence interval (C.I.) 1·8-3·9), of black ethnicity (AOR compared to white: 2·6 95% C.I. 1·7- 182 
3·9), had a higher number of casual UAI partners in the previous year (>10 compared to <2 AOR 21·8, 95% 183 
C.I. 16·2-29·2) or had attended a genitourinary medicine clinic (GUM)  clinic during the previous year (AOR 184 
1·8, 95% C.I. 1·5-2·3) (Table 4). 185 
HIV negative MSM were considered at higher risk of acquiring HIV if they reported UAI with ≥1 casual 186 
partners or reported not to have exclusively serosorted in the previous year.  Overall, this applied to 25·4% 187 
(2633/10364) of negative men fluctuating between 23·0% (n=203/883) and 28·8% (n=377/1308) over the 188 
ten surveys with no significant trend. The mean and median numbers of UAI partners in the previous year 189 
among those at higher risk of acquiring HIV fluctuated between 2·8 and 6·1, and 1 and 2, respectively with 190 
no trend. There was a marked increase in HIV testing in the last year among MSM in this group from 33·8% 191 
(79/234) to 72·5% (111/153) (p<0·001) (Table 3.). Compared to other HIV negative MSM, those at higher 192 
risk of acquiring HIV were more likely to have had a high number of casual UAI partners (>10 compared 193 
to <2 AOR 69·8, 95% C.I. 35·3-138·2, p<0·001) or have been diagnosed with a sexually transmitted 194 
infection (STI) in the previous year (AOR 1·4, 95% C.I. 1·2-1·7) (Table 4). 195 
Discussion 196 
We have shown in a 14 year time series of large-scale surveys amongst MSM in London that HIV 197 
prevalence remains high at around 13%, and that there have been substantial increases in the uptake of 198 
HIV testing and the concomitant decline in the fraction of HIV which remains undiagnosed. Despite these 199 
changes, which may have been expected, combined with improved uptake of treatment to reduce 200 
transmission, HIV incidence remains high and unchanged.3;4 Our data show that irrespective of the 201 
positive changes in testing uptake, risk behaviour has increased over this period characterised by 202 
increased UAI and increasing numbers of sexual partners, particularly among HIV positive men and those 203 
who remain at risk of transmission. We have shown that serosorting, which has increased substantially 204 
over the last 14 years, is a risky practice, particularly amongst negative men since 3% (in 2013) of those 205 
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who perceive themselves to be negative are positive and inadvertently putting others at risk. We have 206 
identified and characterised a subgroup at risk of transmitting infection, in particular undiagnosed men 207 
reporting UAI ( one in 43 MSM) and a larger group at risk of acquiring infection (one in five negative MSM) 208 
in whom maintenance of the epidemic may be occurring. As not all diagnosed MSM are on treatment 209 
(69% in 2000 (personal communication Zheng Yin), 90% in 20132) and of those on treatment, not all have 210 
undetectable viral loads (94% in 2013)2, a fraction of those diagnosed reporting UAI and not exclusively 211 
serosorting are also likely to be at risk of transmission. Furthermore, increased uptake of recent testing, 212 
combined with evidence of undiagnosed HIV positives amongst those who have recently tested negative, 213 
suggest that an increasing proportion of the undiagnosed fraction may be recent infections posing high 214 
risk of transmission. 215 
This study examined long term trends in undiagnosed HIV, testing, UAI, serosorting and partner numbers 216 
by HIV status among MSM in London. It sheds light on the changes in behaviours and testing alongside 217 
other current available information on testing1;16 and ARV treatment uptake1;17. It is known that some HIV 218 
positive individuals change their behaviour shortly after diagnosis18 and here we are able to present 219 
differences by  HIV infection status and further explore a large group of undiagnosed MSM. In addition, 220 
we were able to identify HIV positive (particularly undiagnosed) MSM reporting behaviours conducive to 221 
transmission. These data will be of value to modelling studies, as we are able to provide key parameters 222 
such as rate of partner change and the proportion of the population at risk. 223 
 224 
A limitation of the study is that for MSM at risk of transmitting HIV, we had no information on the timing 225 
of infection in relation to contact with sexual partners, or how many diagnosed individuals were on 226 
treatment and had undetectable viral load. Among HIV diagnosed men potentially at risk of transmitting, 227 
the proportion diagnosed with an STI in the last year was double that compared to other MSM (39% vs. 228 
17%) which may have increased their risk of transmission. Secondly, the increase in recent testing among 229 
the undiagnosed is only suggestive of undiagnosed infection being increasingly recently acquired, as we 230 
cannot know length of infection among men that did not test.  231 
 232 
Thirdly, the surveys were convenience samples and may lack generalisability and/or comparability over 233 
time which may partially explain the lack of some observed trends. Response rates varied between 50% 234 
and 70% and we are unable to say how non-responders differed in risk. Among the 13% that refused a 235 
test, the demographic characteristics were broadly the same as those that did test, although we are 236 
unable to infer differences in HIV status.  Also, the self-reported behaviour and testing data may be 237 
subject to recall bias. Further, new web- or app-based methods to meet partners have become 238 
increasingly popular19 and MSM who use these may differ from those visiting bars, clubs and saunas; a 239 
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study comparing MSM recruited to online and offline behavioural surveillance studies showed that those 240 
using web-based methods were younger, less gay identified, less likely to use condoms with casual 241 
partners and less likely to test for HIV.20 In addition, London-based MSM may not be representative of 242 
MSM in the UK; in the capital the estimated HIV prevalence is one in 11 MSM compared to one in 28 in 243 
England and Wales outside London.21 However, due to the low MSM population prevalence, it is not 244 
feasible to obtain a true probability sample. Unlike many convenience samples or internet samples, we 245 
did have a clear sampling frame and calculated a response rate. Data from the National Survey of Sexual 246 
Attitudes and Lifestyles (NATSAL) show that in 2000, 61.6% (95% CI: 52.8-69.7) of MSM had attended a 247 
gay club or bar in the last year and in 2010 this was 55% (95% CI: 44.7-64.9) (personal communication 248 
Catherine Mercer). Among gay-identifying MSM, 77.5% (95% C.I. 64.3-86.8) had attended such venues in 249 
the last year. Comparison of data from MSM in convenience sample surveys and NATSAL (2010) show 250 
that the former are likely to overestimate rates of STI diagnoses and HIV testing but that these differences 251 
are smaller among gay-identifying MSM22, suggesting our findings may be generalizable to gay-identifying 252 
MSM.  By obtaining trends from similar venues over an extended time frame, we were able to make 253 
comparisons over time.  Lastly, some participants may not have accurately disclosed their status 254 
potentially inflating our estimate of the undiagnosed. However, we believe nondisclosure was kept to a 255 
minimum as the self-completed survey was entirely anonymous.  256 
 257 
To our knowledge, few UK studies exist which examine trends in sexual behaviours among MSM in the 258 
community by HIV status and none that have reported trends in MSM partner numbers in detail by HIV 259 
transmission risk. Most are cross-sectional data from earlier rounds of surveys included in this 260 
study.14;15;23;24 A study by Lattimore et al. which examined the sexual behaviour of gay men in London 261 
using gyms between 1998 and 2008 found a lower proportion of MSM reporting UAI than in our study 262 
(36·6% vs. 50% in our study in 2008) but also an increase in UAI with partners of the same status 263 
particularly among HIV negative MSM from 12·4% in 1998 to 21·1% in 2008.25 A study by McDaid et al. on 264 
both serosorting and strategic positioning during UAI among MSM in Scotland found that, although these 265 
were occurring (among 11% of HIV positive and 13% of negative MSM in 2008), they were performed 266 
inconsistently.26 Both of these studies also found increased HIV testing (ever and recent) among MSM. 267 
Continuing high levels of undiagnosed infection among MSM in the community has been reported also in 268 
Scotland (25·4% in 2011).27 To note is that HIV epidemics among MSM in numerous other countries are 269 
similar to that in the UK.  For example, reports show that in France and the United States, also despite 270 
increases in ARV coverage and testing, transmission is sustained at a high level,28;29 likely due to increased 271 
risk behaviours similar to those shown here. 272 
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This study emphasises the importance of core groups in the epidemiology and control of HIV infection 273 
among the UK MSM community. The data show changes in sexual risk behaviours of MSM in London over 274 
the last 14 years with more reporting UAI and using serosorting as a risk reduction strategy. As may be 275 
expected, there are distinct differences in risk behaviours of MSM by HIV status with positive men 276 
describing the highest risk. A subgroup of these are infectious, particularly the undiagnosed and, coupled 277 
with high partner numbers, and the one in five negative men at risk of acquisition, they are likely to 278 
disproportionately be the drivers of the sustained incidence over the last decade. The benefits of 279 
serosorting may be outweighed by increased partner numbers, inconsistent practice and incorrect 280 
perceived serostatus as demonstrated by the high proportion of undiagnosed men who incorrectly 281 
perceive their status as negative. In addition, the rise in testing rates among the undiagnosed suggests 282 
these infections are increasingly recently acquired, when persons may be most infectious. 283 
 284 
Modelling studies have shown that reducing the number of undiagnosed infections and subsequently 285 
treating them will have the greatest impact on HIV incidence.30;31 There is a high level of undiagnosed HIV 286 
infection in the community, particularly in saunas where nearly one in 10 men were undiagnosed. 287 
Community–level interventions in settings such as bars, clubs and saunas have been shown to be 288 
successful32 and not to deter clientele33. Further, self-sampling and self-testing is acceptable to MSM34 289 
and now available in the UK, which could promote testing at more regular intervals, and would be 290 
important in earlier detection of infection to reduce transmission, in particular among those less likely to 291 
frequent sexual health clinics. Anecdotal evidence suggests the recent increase in new diagnoses and 292 
infections in London1 may also partly been attributable to other behaviours not studied here such as an 293 
increase in recreational drug use.35 As Kirby et al report, MSM attending the central London CODE clinic 294 
(a clinic which specialises in sexual health for men who use drugs for sex referred to as chemsex) prefer 295 
to use internet sites which specialise in ‘barebacking’ (UAI) to find partners, with an average of five 296 
partners per episode reported.35 Further work is needed to design interventions which also reach the 297 
users of these sites. 298 
 299 
Whilst HIV testing is increasing1, and the coverage of ARV is high among people diagnosed, the prevalence 300 
of high risk behaviours among MSM visiting gay social venues remains high. It has been demonstrated 301 
that treatment as prevention strategies are unlikely to have a significant impact on HIV incidence in the 302 
UK,  due to transmission from men with primary infection and undiagnosed cases.36 We have shown here 303 
that a large fraction of undiagnosed infection is now recently acquired infection and a proportion of these 304 
are likely primary infections. In addition, modelling studies have found the epidemiological effect of 305 
earlier diagnosis and treatment to be offset by increases in risk behaviours.37;38 Pre-exposure prophylaxis 306 
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(PreP) may help prevent outbreaks among those with early infection, however it relies on MSM perceiving 307 
themselves at risk and choosing to test; in our study a third of undiagnosed MSM had not tested within 308 
the last year. Finally, it must be emphasised that serosorting, where the status of the partner is presumed, 309 
is unsafe due incorrect perception of serostatus. Thus, there is an urgent need for public health authorities 310 
to put more focus on behaviour change interventions alongside other possible biomedical interventions 311 
currently being evaluated, such as test and treat and PreP programmes, targeting in particular the core 312 
group of ‘potential transmitters’, as well as those negative with behavioural patterns putting themselves 313 
at high-risk of acquisition. The social and cultural mixing between these groups will need to be considered 314 
as part of the design of risk reduction strategies, e.g. targeting in particular younger MSM who may be 315 
less aware of the risks and/or less able to protect themselves. These findings are an important 316 
contribution to the growing evidence that testing and treat strategies alone are not sufficient to reduce 317 
HIV incidence at population level. Combination prevention working closely with affected communities, to 318 
reduce communitywide risk by both behavioural and biological interventions, is critical if we are to move 319 
towards eradication of HIV. 320 
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 329 
Panel: Research in context 330 
 331 
Evidence before this study 332 
We conducted a systematic review searching PubMed for articles published in English up until 14th June 333 
2015 using the terms: “sexual behaviour”, “MSM”, “homosexuality or male” “trends”, “HIV”, “HIV 334 
infections” or “HIV antibodies” or “HIV seropositivity” or “saliva” or “incidence” or “prevalence,” “UK”, 335 
“Great Britain”. There has only been one other study examining trends in sexual behaviours among UK 336 
MSM (recruited from gyms across London) between 1998-2008, which found lower rates of MSM 337 
reporting unprotected anal intercourse (UAI) overall, but also an increase in the proportion of men 338 
reporting UAI and to serosort. There are no studies showing trends in sexual behaviours in the UK in more 339 
recent years and none showing trends in numbers of sexual partners in this population. One recent cross-340 
sectional study among HIV positive MSM recruited from HIV clinics between 2011 and 2012 showed a 341 
lower prevalence of UAI (38%) and serosorting (28%). Another cross-sectional study in 2008 also found a 342 
lower prevalence of serosorting and strategic positioning during UAI among MSM in Scotland with 11% 343 
among HIV positive and 13% among negative MSM. Three modelling studies which used multiple national 344 
surveillance databases show trends in undiagnosed HIV infection to not have declined and HIV testing to 345 
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have increased. In addition, similar patterns were found in community-based surveys conducted in 346 
Scotland, and England. 347 
 348 
 349 
 Added value of this study 350 
Our data indicate changes in sexual risk behaviours with increasing rates of UAI and serosorting, the latter 351 
considered to be a risk reduction strategy. Our findings emphasise the importance of core groups in the 352 
epidemiology and control of HIV infection in MSM in the UK, with one in 20 identified as being potentially 353 
at risk of transmitting and one in four at risk of acquiring HIV. Undiagnosed HIV infection may be 354 
increasingly recently acquired infection, during which persons are most infectious. This coupled with the 355 
high partner numbers of a core group of MSM potentially at risk of transmitting HIV, and the lack of 356 
decline in the proportion at men at risk of acquiring the infection, may explain the sustained HIV incidence 357 
in the UK, despite increases in HIV testing and ARV coverage.  358 
 359 
Implications of all the available evidence 360 
There is growing evidence that test and treat interventions alone are not sufficient to reduce HIV 361 
incidence at population level. Combination prevention interventions will be critical for countries with 362 
similar epidemics among MSM.  363 
 364 
 365 
 366 
 367 
 368 
 369 
 370 
 371 
 372 
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Table 1 Trends in HIV positivity and HIV testing among MSM in Londona, d, 2001-2013 373 
 374 
 375 
a Determined by Orasure oral fluid specimen  376 
b Adjusted for age, education , ethnicity and employment 377 
c p-value for association between outcome and survey year (categorical) as data showed evidence of departure from linearity 378 
d Denominators vary due to incomplete data on all variables 379 
 380 
 381 
 382 
 383 
 Year  
Total 
% (n) 
2000 
% (n) 
2001 
% (n) 
2002 
% (n) 
2003 
% (n) 
2004 
% (n) 
2005 
% (n) 
2006 
% (n) 
2008 
% (n) 
2011 
% (n) 
2013 
% (n) 
p-valueb 
% HIV positive All MSM 12.7 
(1512/11876) 
11.0 
(132/1206) 
11.5 
(150/1309) 
12.1 
 (126/1043) 
12.2 
(177/1432) 
12.8 
(177/1377) 
12.9 
(195/1503) 
17.4 
(200/1153) 
15.0 
(167/1106) 
8.5 
(82/965) 
13.6 
(106/782) 
p<0.001 c 
%   
undiagnosed HIV + MSM 
35.3 
(531/1505) 
34.4 
(45/131) 
49.3 
(74/150) 
33.9 
(42/126) 
44.1 
 (78/177) 
41.2 
 (73/177) 
29.0 
 (56/193) 
34.9 
 (68/197) 
28.1 
 (46/166) 
29.3 
 (24/82) 
23.6 
(25/106) 
p=0.01 c   
% ever tested 
for HIV 
All MSM  
79.4 
(9184/11568) 
63.1 
(629/997) 
69.3 
(900/1297) 
75.9 
(788/1035) 
78.0 
(112/1240) 
78.1 
(1065/1363) 
80.4 
(1195/1487) 
83.4 
(952/1142) 
89.1 
(972/1092) 
89.9 
(862/958) 
91.3 
(709/777) 
p<0.004 
HIV-   
77.6 
(7886/10161) 
61.6 
(567/920) 
66.9 
(770/1150) 
74.9 
(683/912) 
76.5 
(955/1288) 
76.0 
(904/1189) 
78.6 
(1024/1303) 
81.1 
(770/950) 
87.5 
(818/935) 
89.4 
(787/880) 
90.1 
 (608/674) 
p<0.001 
HIV + undiag 78.9   
(408/517) 
57.1 
 (20/35) 
77.0 
 (57/74) 
57.1 
 (24/42) 
80.3 
(61/76) 
82.1 
 (60/73) 
76.8 
(43/56) 
85.3 
(58/68) 
93.3 
 (42/45) 
87.5 
(21/24) 
91.7 
(22/24) 
p<0.001 
% tested for 
HIV in the past 
year 
All MSM  42.3 
(4891/11568) 
26.4 
(263/997) 
32.4 
(421/1297) 
36.2 
(375/1035) 
38.6 
(550/1420) 
42.3 
(576/1363) 
43.1 
(634/1487) 
44.0 
(504/1142) 
51.4 
(560/1092) 
55.5 
(532/958) 
60.1 
 (467/777) 
p<0.001 
HIV-   42.2 
(4312/10161) 
26.2 
 (241/920) 
32.1 
(370/1150) 
36.6 
(334/912) 
38.6 
(482/1248) 
41.58 
(498/1198) 
43.2 
(563/1303) 
44.4 
(422/950) 
51.9 
(485/935) 
56.9 
(501/880) 
61.7 
(416/674) 
p<0.001 
HIV + undiag 43.3   
(224/517) 
28.6 
(10/35) 
29.7  
(22/74) 
21.4 
 (9/42) 
46.1  
(35/76) 
49.3  
(36/73) 
39.3  
(22/56) 
55.1  
(38/68) 
53.3  
(24/45) 
50.0 
(12/24) 
66.7  
(16/24) 
p<0.001 
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Table 2 Trends in sexual behaviours among MSM by HIV status a,c, 2000-2013 384 
a Determined by Orasure oral fluid specimen 385 
b Adjusted for age 386 
c Denominators vary due to incomplete data on all variables 387 
 388 
 389 
  Year  
Total 
% (n) 
2000 
% (n) 
2001 
% (n) 
2002 
% (n) 
2003 
% (n) 
2004 
% (n) 
2005 
% (n) 
2006 
% (n) 
2008 
% (n) 
2011 
% (n) 
2013 
% (n) 
p-valueb 
% had UAI in 
the last year 
HIV - 45.9 
(4651/10139) 
42.3 
(448/1058) 
44.8 
(510/1138) 
41.7 
 (378/907) 
45.9 
(567/1235) 
42.8 
(502/1173) 
49.0 
(633/1291) 
46.5 
(431/927) 
46.7 
(430/920) 
50.2 
(423/843) 
50.9 
(329/647) 
p<0.001 
HIV+   diag 
59.5 
(556/934) 
48.8 
(41/84) 
47.3  
(35/74) 
58.2 
(46/79) 
61.7 
 (58/94) 
66.3 
 (65/98) 
54.3 
 (70/129) 
65.6 (82/125) 63.8 (74/116) 
61.8 
 (34/55) 
63.8 
(51/80) 
p=0.002 
HIV + undiag 53.9 
(268/497) 
53.3 
(24/45) 
59.2 
(42/71) 
53.8 
 (21/39) 
44.0 
(33/75) 
56.7 
(38/67) 
61.5 
(32/52) 
55.6 
(35/63) 
42.9 
 (18/42) 
52.4 
(11/21) 
63.6 
(14/22) 
p=0.93 
All 47.3 
(5475/11570) 
43.2 
(513/1187) 
45.8 
(587/1283) 
43.4 
(445/1025) 
46.9 
(658/1404) 
45.2 
(605/1338) 
49.9 
(735/1472) 
49.2 
(548/1115) 
48.4 
(522/1078) 
50.9 
(468/919) 
52.6 
(394/749) 
p<0.001 
%  exclusively 
serosorted in 
the last year 
HIV - 
21.2 
(1942/9166) 
18.0 
(181/1007) 
17.5 
(178/1015) 
16.9 
(143/844) 
21.2 
(242/1144) 
18.6 
(198/1067) 
23.5 
(271/1155) 
22.8 
(186/817) 
23.9 
(200/838) 
26.6 
(193/725) 
27.1 
(150/554) 
p<0.001 
HIV+   diag 
26.1 
(225/862) 
21.7  
(18/83) 
19.1  
(13/68) 
20.8  
(15/72) 
29.5 
(26/88) 
30.4 
(28/92) 
24.2 
(30/124) 
27.2  
(31/114) 
30.5  
(32/105) 
23.4 
(11/47) 
30.4 
 (21/69) 
p=0.06 
HIV + undiag 
14.6 (64/438) 19.0 
 (8/42) 
9.4 
 (6/64) 
8.8 
 (3/34) 
11.9 
(8/67) 
10.0 
 (6/60) 
19.6 
(9/46) 
13.2  
(7/53) 
20.5 
 (8/39) 
17.7 
 (3/17) 
37.5  
(6/16) 
p=0.033 
All 21.3 
(2231/10466) 
18.3 
(207/1132) 
17.2 
(197/1147) 
17.0 
(161/950) 
20.6 
(267/1299) 
19.0 
(232/1219) 
23.4 
(310/1325) 
22.7 
(224/984) 
24.4 
(240/982) 
26.4 
(207/789) 
27.7 
(177/639) 
p<0.001 
% reported UAI 
with partners 
of 
unknown/disco
rdant HIV 
status in the 
last year 
HIV - 19.1 
(1748/9166) 
21.7 
(218/1007) 
20.8 
(211/1015) 
20.5  
(173/844) 
20.5 
(235/1114) 
18.7 
(200/1067) 
19.8 
(229/1155) 
16.7 
(136/817) 
17.7 
(148/838) 
15.5 
(112/725) 
15.5 
(86/554) 
p<0.001 
HIV+   diag 30.1  
(259/862) 
26.5 
(22/83) 
23.5 
(16/68) 
33.3 
(24/72) 
29.6 
 (26/88) 
33.7 
 (31/92) 
28.2 
(35/124) 
35.1 
(40/114) 
29.5 
(31/105) 
31.9 
 (15/47) 
27.5 
(19/69) 
p=0.433 
HIV + undiag 33.3  
(146/438) 
31.0 
 (13/42) 
45.3 
(29/64) 
38.0 
 (13/34) 
25.4 
 (17/67) 
43.3 
(26/60) 
37.0 
 (17/46) 
34.0 
 (18/53) 
18.0 
(7/39) 
23.5 
 (4/17) 
12.5 
(2/16) 
p=0.012 
All 20.6 
(2153/10466) 
22.3 
(253/1132) 
22.3 
(256/1147) 
22.1 
(210/950) 
21.4 
(278/1299) 
21.1 
(257/1219) 
21.2 
(281/1325) 
19.7 
(194/984) 
18.9 
(186/982) 
16.6 
(131/789) 
16.7 
(107/639) 
p<0.001 
Number of UAI 
partners in the 
last year 
mean (SD); 
median(IQR) 
HIV - 1.4 (6.8) 
0 (0,1) 
 
0.9 (3.2); 
 0 (0,1)  
1.6 (5.9); 
0 (0,1) 
1.2 (5.0); 
0 (0,1) 
1.4 (4.9); 
0 (0,1) 
1.3 (7.1); 
0 (0,1) 
1.7 (11); 
0 (0,1) 
1.3 (4.3); 
0 (0,1) 
1.3 (4.6); 
0 (0,1) 
1.4 (3.6); 
0 (0,1) 
1.9 (12.5); 
0 (0,1) 
p=0.073 
HIV+   diag 
9.2 (30.7) 
1 (0,5) 
4.7 (12.8);  
0 (0,2) 
4.6 (14.7);  
0 (0,2) 
8.3 (24.9); 
1 (0,7) 
7.9 (22.5);  
1 (0,4) 
7.1 (15.6);  
2 (0,5) 
9.3 (45.0); 
1 (0,5) 
13.5 (36.8); 
1 (0,5) 
11.8 (42.1); 
1 (0,5) 
12.6 (31.8); 
1 (0,11) 
9.7 (22.5); 
1 (0,10) 
p=0.008 
HIV + undiag 4.1 (17.5) 
1 (0,2) 
1.6 (3.5); 
1 (0,1) 
3.8 (6.5); 
1 (0,3) 
2.9 (8.4); 
1 (0,1) 
5.3 (34.6); 
0 (0,2) 
6.5 (22.4); 
1 (0,2) 
4.5 (7.8); 
1 (0,4.5) 
4.0 (13.9); 
1,(0,2) 
1.5 (3.3); 
0,(0,2) 
1.2 (2.2); 
1(0,1) 
7.4 (13.9) 
1(0,5) 
p=0.77 
All 
2.1 (11.6) 
0 (0,1) 
1.2 (4.7); 
0 (0,1) 
1.9 (6.9); 
0 (0,1) 
1.8 (8.7); 
 0 (0,1) 
2.0 (11.0); 
0 (0,1) 
2.0 (9.5); 
0 (0,1) 
2.5 (17.0); 
0 (0,1) 
2.8 (13.8); 
0 (0,1) 
2.4 (14.8); 
0 (0,1) 
2.0 (8.9); 
1(0,1) 
2.9 (14.2); 
1(0,1) 
p=0.001 
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Table 3 Trends in the proportion of MSM potentially at risk of transmitting and acquiring HIV, their number of UAI partners in the previous year and 390 
recent testing among those at risk of acquiring HIV 2000-2013a, b 391 
   Year  
Total 
%(n) 
2000 
% (n) 
2001 
% (n) 
2002 
% (n) 
2003 
% (n) 
2004 
% (n) 
2005 
% (n) 
2006 
% (n) 
2008 
% (n) 
2011 
% (n) 
2013 
% (n) 
p-valuec 
Potentiall
y at risk 
of 
transmitti
ng HIVd 
Undiagnosed 
MSM 
reporting 
UAI in the 
previous 
year 
As a % of all MSM  
2.3 
 (268/11570) 
2.0 
 (24/1187) 
3.3 
(42/1283) 
2.1 
(21/1025) 
2.4 
(33/1404) 
2.8 
(38/1338) 
2.2 
(32/1472) 
3.1 
(35/1115) 
1.7 
 (18/1078) 
1.2 
 (11/919) 
1.9 
(14/749) 0·09 
As a % of MSM having UAI   
4.9 
 (568/5475) 
4·7  
(24/513) 
7·2 
(42/587) 
4·7 
(21/445) 
5·0  
(33/658) 
6·3  
(38/605) 
4·4 
 (32/735) 
6·4  
(35/548) 
3·5  
(18/522) 
2·4 
 (11/468) 
3·6 
(14/394) 
0.005 
Mean (SD) number of UAI 
partners  g 
7.6 
 (23.2) 
3  
(4.4) 
6.5 
(10.2) 
5.5 
(11.0) 
12 
(51.8) 
11.4 
(28.9) 
7.4 
(8.9) 
7.1 
(18.2) 
3.5 
4.4) 
2.4 
(2.7) 
11.6 
(16.1) 
0·62 
Median (IQR) of n UAI 
partners   g 
2 
(1,5) 
1  
(1,2) 
3 
(1,10) 
1 
(1,5) 
2 
(1,4) 
2 
(1,3) 
3 
(1,10) 
2 
(1,4) 
2 
(1,4) 
1 
(1,3) 
2.5  
(1,20) 
1.0 
Diagnosed 
MSM 
reporting  
UAI and not 
exclusively 
serosorting 
in the 
previous 
yeare 
As a % of all MSM  
2.2 
 (259/11570) 
1.9 
(22/1187) 
1.3 
(16/1283) 
2.3  
(24/1025) 
1.9 
(26/1404) 
2.3 
(31/1338) 
2.4 
(35/1472) 
3.6 
(40/1115) 
2.9 
(31/1078) 
1.6 
(15/919) 
2.5 
(19/749) 
0.07 
As a % of MSM having UAI   
4.7  
(259/5475) 
4.3  
(22/513) 
2.7 
(16/587) 
5.4  
(24/445) 
4.0 
(26/658) 
5.1 
(31/605) 
4.8 
(35/735) 
7.3 
(40/548) 
5.9 
(31/522) 
3.2 
(15/468) 
4.8 
(19/394) 
0.47 
Mean (SD) number of UAI 
partners  g 
17.8 
 (39.5) 
13.4 
 (21.3) 
16.1 
 (27.6) 
13.8  
(17.4) 
13.9  
(23.4) 
12  
(23.0) 
9.5  
(11.5) 
28.8  
(56.0) 
24.0  
(71.5) 
22.7 
 (51.6) 
22.4  
(30.0) 
 
0.05 
Median (IQR) of n UAI 
partners   g 
5  
(2,15) 
7  
(2,15) 
4 
 (1,14) 
7  
(3,16) 
3.5  
(2,8) 
4  
(2,15) 
5  
(2,10) 
5  
(2,16) 
5  
(2,15) 
2  
(1,20) 
10  
(2, 28) 
0.45 
Total As a % of all MSM 
4.6  
(527/11570) 
3·9 
 (46/1187) 
4·5  
(58/1283) 
4·4  
(45/1025) 
4·2  
(59/1404) 
5·2 
(69/1338) 
4·6  
(67/1472) 
6·7 
(75/1115) 
4·6 
 (49/1078) 
2·8 
 (26/919) 
4·4 
(33/749) 
0·96 
Not reporting risk of 
transmitting HIV f 
As a % of all MSM  95·5 
(11,043/11570) 
96·1 
(1141/1187) 
95·5 
(1225/128
3) 
95·6 
(980/1025) 
95·8 
(1345/140
4) 
94·8 
(1269/133
8) 
95·5 
(1405/147
2) 
93·3 
(1040/111
5) 
95·5 
(1029/107
8) 
97·2 
(893/919) 
95·6 
(716/749) 
0·96 
As a % of MSM having UAI   90·4 
(4948/5475) 
91·0 
(467/513) 
90·1 
(529/587) 
89·9 
(400/445) 
91·0 
(599/658) 
88·6 
(536/605) 
90·9 
(668/735) 
86·3 
(473/548) 
90·6 
(473/522) 
94·4 
(442/468) 
91·6 
(361/394) 
0·13 
Mean (SD) number of UAI 
partners  g 
1.6 
 (9.2) 
1·0 
(3·3) 
1·5 
(5·8) 
1·4 
(8·1) 
1·5 
(6·9) 
1·5 
(7·3) 
2·2 
(17·2) 
1·7 
(7·0) 
1·7 
(8·1) 
1·7 
(5·6) 
2·2 
(13·1) 
0·004 
Median (IQR) of n UAI 
partners   g 
0 
(0,1) 
0  
(0,1) 
0  
(0,1) 
0  
(0,1) 
0  
(0,1) 
0  
(0,1) 
0  
(0,1) 
0  
(0,1) 
0  
(0,1) 
0 
(0,1) 
1 
(0,1) 1·0 
At higher risk of acquiring 
HIV gh 
As a % of all MSM 
22.8 
(2633/11570) 
23·6  
(280/1187) 
23·3 
(299/1283
) 
23·0 
(236/1025) 
24·3 
(341/1404
) 
21·5 
(288/1338
) 
25·6 
(377/1472
) 
19·5 
(217/1115
) 
22·1 
(238/1078
) 
22·1 
(203/919) 
20·6 
(154/749) 
0·275 
As a % of all HIV negative 
MSM  
25.4 
(2633/10364) 
26·1 
(280/1074) 
25·8 
(299/1159
) 
25·7 
(236/917) 
27·2 
(341/1255
) 
24·0 
(288/1200
) 
28·8 
(377/1308
) 
22·8 
 (217/953) 
25·4 
(238/939) 
23·0  
(203/883) 
22·8 
(154/676) 
0·16 
Mean (SD) of n UAI 
partners  g 
4.2  
(12.8) 2·8 (5·7) 5·1 (10·8) 3·4 (9·0) 3·8 (8·2) 4·5 (13·9) 4·8 (20·0) 4·2 (8·1) 3·7 (8·4) 3·8 (6·0) 6·1 (25·2) 0·252 
Median (IQR) of n UAI  g 
2  
(1,3) 1·5 (1,2) 2 (1,4) 1 (1,3) 1 (1,3) 2 (1,3) 2 (1,4) 2 (1,3) 2 (1,3) 2 (1,3) 2 (1,4) 1·0 
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a Determined by Orasure oral fluid specimen 392 
b Denominators vary due to incomplete data on all variables 393 
cAdjusted for age 394 
dMSM with undiagnosed HIV who reported UAI in the previous year or MSM with diagnosed HIV who reported UAI and to not have exclusively serosorted. 395 
e no ART or VL data available so we were unable to ascertain if men in this group were on treatment and had undetectable viral loads and therefore not at risk of transmitting HIV. 396 
f all MSM not included in d who provided information on number of UAI partners 397 
g In the last year 398 
h  HIV- MSM reporting ≥ 1 casual UAI partner  or not exclusively serosorting  in the last year 399 
 400 
 401 
 402 
 403 
 404 
 405 
 406 
 407 
 408 
 409 
 410 
 411 
 412 
% tested for HIV in the last 
year 
50.1 
(1288/2573) 
33·8 
 (79/234) 
36·4 
(108/297) 
43·6 
(102/234) 
46·6 
(157/337) 
49·7 
(141/284) 
52·9 
(199/376) 
50·7 
(110/217) 
58·0 
(138/238) 
70·4 
(143/203) 
72·5 
(111/153) 
<0·001 
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Table 4 Factors associated with potential risk of transmitting and higher risk of acquiring HIV in MSM, 2000-2013 combined 413 
 414 
a includes  MSM with undiagnosed HIV who report UAI in the previous year and MSM  with diagnosed HIV  who report UAI and not to have exclusively serosorted in the last year; compared to all other MSM 415 
b includes HIV negative MSM who either report 1+UAI casual partner or not exclusively serosorting  in the last year; compared to all other HIV negative MSM 416 
c denominators vary due to incomplete data on all variables 417 
d adjusted for age and year of survey 418 
e multivariable model includes variables that were p<0·05 ind 419 
 420 
 421 
 422 
 423 
 424 
  MSM potentially at risk of transmitting HIV a  MSM at  higher risk of acquiring HIVb 
Characteristic % (n/N) c OR (95 % C.I.) d p-value AOR (95 % C.I.) e p-value % (n/N)  OR (95 % C.I.)d p-value AOR (95 % C.I.) e p-value 
Total 4·6 (527/11570) N/A N/A  25·4 (2633/10364) N/A  N/A  
Age 
16-24 2·5 (40/1583) 1.0 
0.0002 
1·0 
<0·0001 
30·2 (469/1554) 1.0  1·0 
0·003 
25-34 4·6 (217/4735) 1·85 (1·32-2·60) 2·11 (1·45-3·08) 26·6 (1146/4317) 0·84 (0·74-0·95) 
<0·0001 
0·94 (0·79-1·12) 
35-44 5·4 (195/3635) 2·19 (1·55-3·09) 2·67 (1· 82-3·92) 24·1 (745/3090) 0·74 (0·64-0·85) 0·83 (0.69-1.00) 
45-64 4·8 (70/1455) 1.94 (1·31-2·89) 2·55 (1·64-3·97) 20·1 (250/1245) 0·59 (0·49-0·70) 0·62 (0·49-0·80) 
65+ 1·2 (1/82) 0·48 (0·06-3·50) 0·89 (0·11-7·21) 11·3 (9/80) 0·30 (14·6-59·6) 0·39 (0·15-1·04) 
Ethnicity 
White 4·4 (434/9973) 1·0 
<0·0001 
1·0 
 
0·0001 
25·5 (2269/8912) 1.0 
0·14 
-- 
-- 
Black  11·5 (41/356) 2·86 (2·04-4·01) 2·60 (1·73-3·90) 26·5 (76/287) 1·06 (0.81-1.38) -- 
Asian         3·2 (10/314) 0·72 (0·38-1·37) 0·83 (0·43-1·64) 23·6 (73/310) 0·90 (0.69-1.18) -- 
South East Asian          2·5 (5/204) 0·55 (0·23-1·35) 0·71 (0·28-1·81) 18·3 (36/197) 0·65 (0.45-0.94)  -- 
Mixed/other 5·2 (36/689) 1·21 (0·85-1·71) 1·21 (0·82-1·79) 26·8 (168/628) 1·09 (0.90-1.31) -- 
Years education post age 16 
None  5·2 (69/1325) 1·0 
0·0002 
1.0 
0·03 
28·1 (314/1116) 1·0 
0·003 
1·0 
0·18 
Up to 2 years 6·3 (119/1888) 1·22 (0·90-1·66) 1·32 (0·94-1·85) 27·9 (459/1648) 0·99 (0·84-1·17) 0·91 (0·72-1·13) 
3 years or more 4·1 (306/7459) 0·77 (0·59-1·01) 0·91 (0·68-1·23) 24·3 (1637/6741) 0·83 (0·72-0·95) 0·82 (0·68-0·99) 
Still in full time education 3·7 (30/820) 0·69 (0·44-1·06) 0·99 (0·60-1·63) 27·3 (213/779) 0·97 (0.79-1·19) 0·85 (0·64-1·14) 
Employed 
No 5·8 (87/1508) 1·0 
0·011 
1·0 
0·81 
27·4 (342/1247) 1·0 
0.09 
1·0 0·96 
Yes 4·4 (437/10021) 0·75 (0·59-0·95) 0·97 (0·74-1·27) 25·2 (2289/9091) 0·89 (0·78-1·02) 1·02 (0·84-1·24) 
Age of first AI <16 years 
 No 4·4 (410/9393) 1·0 
<0·0001 
1·0 
0·054 
25·8 (2176/8429) 1·0 
<0·0001 
1·0 0·42 
  Yes 7·5 (110/1463) 1·78 (1·43-2·22) 1·27 (1·00-1·63) 33.3 (406/1218) 1·44 (1·26-1·64) 1·11 (0·94-1·33) 
Casual UAI partners in the last year 
 <2 1·8 (168/9264) 1·0 
<0·0001 
1·0 
<0·0001 
 
14·6 (1227/8380) -- 
<0·0001 
1·0 
<0·0001 
2-5 11·0 (180/1633) 6·73 (5·42-8·37) 5·50 (4·37-6·91) 76·9 (1046/1360) 19·7 (17·1-22·7) 17·9 (15·4-20·9) 
6-10 18·7 (64/343) 12·5 (9·15-17·06) 9·83 (7·08-13·64) 89.9 (218/245) 48·0 (32·0-71·9) 54·4 (33·3-88·8) 
>10 34·9 (115/330) 29·3 (22·3-38·51) 21·77 (16·23-29·19) 92.2 (142/154) 70·2 (38·8-127·0) 69·8 (35·3-138·2) 
STD in the last year 
 No 3·.4 (321/9391) 1·0 
<0·0001 
1·0 
0·058 
22·5 (1938/8610) 1·0 
<0·0001 
1·0 
<0·001 
 Yes 9.7 (202/2083) 3·05 (2·54-3·67) 1·24 (0·99-1·55) 40·4 (671/1661) 2·32 (2·08-2·59) 1·43 (1·22-1·68) 
Attended a GUM clinic in the last year 
No 2·5 (154/6199) 1·0 
<0·0001 
1·0 
<0·0001 
21·5 (1275/5537) 1·0 
<0·0001 
1·0 
0·12 
Yes 7·0 (367/5256) 2·97(2·45-3·60) 1·81 (1·45-2·26) 30·7 (1330/4327) 1·65 (1·50-1·80) 1·10 (0·97-1·25) 
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